BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36233090)

  • 1. Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway.
    Abe A; Imoto I; Ueki A; Nomura H; Kanao H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
    Ramus SJ; Song H; Dicks E; Tyrer JP; Rosenthal AN; Intermaggio MP; Fraser L; Gentry-Maharaj A; Hayward J; Philpott S; Anderson C; Edlund CK; Conti D; Harrington P; Barrowdale D; Bowtell DD; Alsop K; Mitchell G; ; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Sieh W; McGuire V; Lester J; Bogdanova N; Dürst M; Hillemanns P; ; Odunsi K; Whittemore AS; Karlan BY; Dörk T; Goode EL; Menon U; Jacobs IJ; Antoniou AC; Pharoah PD; Gayther SA
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26315354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial ovarian cancer risk: A review of the current genetic landscape.
    Flaum N; Crosbie EJ; Edmondson RJ; Smith MJ; Evans DG
    Clin Genet; 2020 Jan; 97(1):54-63. PubMed ID: 31099061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.
    Paulo P; Cardoso M; Brandão A; Pinto P; Falconi A; Pinheiro M; Cerveira N; Silva R; Santos C; Pinto C; Peixoto A; Maia S; Teixeira MR
    Genes Chromosomes Cancer; 2023 Dec; 62(12):710-720. PubMed ID: 37436117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
    Flaum N; van Veen EM; Smith O; Amico S; Newman WG; Crosbie EJ; Edmondson R; Smith MJ; Evans DG
    Clin Genet; 2022 Jan; 101(1):48-54. PubMed ID: 34585738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.
    Pietragalla A; Arcieri M; Marchetti C; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Nov; 30(11):1803-1810. PubMed ID: 32895312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous Recombination Deficiencies and Hereditary Tumors.
    Yamamoto H; Hirasawa A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    Angeli D; Salvi S; Tedaldi G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.
    Shah S; Cheung A; Kutka M; Sheriff M; Boussios S
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Vysotskaia V; Kaseniit KE; Bucheit L; Ready K; Price K; Johansen Taber K
    Cancer; 2020 Feb; 126(3):549-558. PubMed ID: 31682005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
    Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J
    PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
    Pavanello M; Chan IH; Ariff A; Pharoah PD; Gayther SA; Ramus SJ
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33086730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
    Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
    Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers.
    Janssen B; Bellis S; Koller T; Tischkowitz M; Liau SS
    J Hum Genet; 2020 Jan; 65(2):199-205. PubMed ID: 31619740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.
    Toh M; Ngeow J
    Oncologist; 2021 Sep; 26(9):e1526-e1537. PubMed ID: 34021944
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Vibert R; Le Gall J; Buecher B; Mouret-Fourme E; Bataillon G; Becette V; Trabelsi-Grati O; Moncoutier V; Dehainault C; Carriere J; Schwartz M; Suybeng V; Bieche I; Colas C; Vincent-Salomon A; Stoppa-Lyonnet D; Golmard L
    J Med Genet; 2023 May; 60(5):460-463. PubMed ID: 36270768
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk epithelial ovarian cancer patients for hereditary ovarian cancer.
    Chirasophon S; Manchana T; Teerapakpinyo C
    J Obstet Gynaecol Res; 2017 May; 43(5):929-934. PubMed ID: 28188963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
    Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA
    Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
    Pennington KP; Walsh T; Harrell MI; Lee MK; Pennil CC; Rendi MH; Thornton A; Norquist BM; Casadei S; Nord AS; Agnew KJ; Pritchard CC; Scroggins S; Garcia RL; King MC; Swisher EM
    Clin Cancer Res; 2014 Feb; 20(3):764-75. PubMed ID: 24240112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.